A federal judge has sanctioned a plaintiffs lawyer and reduced the jury award in one of the bellwether cases in the MDL over the anti-osteoporosis drug Fosamax. The judge called the $8 million verdict returned by a jury in favor of plaintiff Shirley Boles "excessive" and gave Boles the option of either getting a retrial on damages or taking $1.5 million. Also, Boles' lawyer, Gary Douglas, was sanctioned $2,500 for conduct that included calling the conduct of the drug's maker, Merck, "reprehensible" and "disgusting."
In Fosamax Case, $8 Million Award Reduced and Attorney Sanctioned
New York Law Journal
October 5, 2010